Physician profile
Sam Stafford
NPI 1164480166
$1,417.46
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,160 · 2020: $224 · 2021: $34.36.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $213.44 | 2019-2020 | |
| Leo Pharma INC. | $174.66 | 2019-2020 | |
| Pfizer INC. | $113.14 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $100.10 | 2019-2020 | |
| Celgene Corporation | $97.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $90.19 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $89.93 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $69.27 | 2019-2020 | |
| Abbvie INC. | $59.47 | 2019-2021 | |
| Prugen, INC. Pharmaceuticals | $47.22 | 2019 | |
| Galderma Laboratories, L.P. | $38.89 | 2019-2020 | |
| Dermira, INC. | $37.87 | 2019 | |
| Vyne Pharmaceuticals INC. | $36.95 | 2020 | |
| Biofrontera INC. | $36.29 | 2019 | |
| Janssen Biotech, INC. | $36.08 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $35.22 | 2019 | |
| Almirall LLC | $30.91 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $30.71 | 2019 | |
| Merz North America, INC. | $19.30 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $18.85 | 2021 | |
| Aclaris Therapeutics, INC. | $14.39 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $13.66 | 2019 | |
| Epi Health, LLC | $12.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Stafford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.